Citrobacter

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Jumpercable (talk | contribs) at 03:20, 26 September 2016 (Clearing up ambiguous language regarding the indole positivity of Citrobacter. C. koseri is the only citrobacter to be commonly indole-positive. The page seemed to previously suggest that citrobacter were all usually capable of the indole reaction). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Citrobacter
Citrobacter freundii
Scientific classification
Kingdom:
Phylum:
Class:
Order:
Family:
Genus:
Citrobacter

Werkman and Gillen, 1932
Species

C. amalonaticus
C. braakii
C. diversus
C. farmeri
C. freundii
C. gillenii
C. koseri
C. murliniae
C. pasteurii[1]
C. rodentium
C. sedlakii
C. werkmanii
C. youngae

Citrobacter is a genus of Gram-negative coliform bacteria in the Enterobacteriaceae family.

The species C. amalonaticus, C. koseri, and C. freundii can use citrate as a sole carbon source. Citrobacter species are differentiated by their ability to convert tryptophan to indole (C. koseri is the only citrobacter to be commonly indole-positive), ferment lactose (C. koseri is a non-lactose fermentor), and use malonate.[2]

Citrobacter shows the ability to accumulate uranium by building phosphate complexes.[3]

Clinical significance

These bacteria can be found almost everywhere in soil, water, wastewater, etc. They can also be found in the human intestine. They are rarely the source of illnesses, except for infections of the urinary tract and infant meningitis and sepsis.[4][5]

C. freundii strains have inducible ampC genes encoding resistance to ampicillin and first-generation cephalosporins. In addition, isolates of Citrobacter may be resistant to many other antibiotics as a result of plasmid-encoded resistance genes.

References

  1. ^ LPSN bacterio.net
  2. ^ Lipsky BA, Hook III EW, Smith AA, et al.: Citrobacter infections in humans: Experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis 1980; 2:746-760.
  3. ^ L. E. Macaskie; R. M. Empson; A. K. Cheetham; C. P. Grey; A. J. Skarnulis (1992). "Uranium bioaccumulation by a Citrobacter sp. as a result of enzymically mediated growth of polycrystalline HUO2PO4". Science. 257 (5071): 782–784. Bibcode:1992Sci...257..782M. doi:10.1126/science.1496397. PMID 1496397.
  4. ^ V. Drelichman; J. D. Band (1985). "Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome". Archives of Internal Medicine. 145 (10): 1808–1810. doi:10.1001/archinte.145.10.1808. PMID 3899035.
  5. ^ Badger, J.D.; M.F. Stins; K.S. Kim (1999). "Citrobacter freundii Invades and Replicates in Human Brain Microvascular Endothelial Cells". Infection and Immunity. 67 (8): 4208–15. PMC 96726. PMID 10417193.

External links